Longeveron (LGVN) Return on Sales [ROS] (2020 - 2026)
Longeveron's Return on Sales [ROS] was -2150.17% in Q2 2026, down 442.26 percentage points from -1707.91% a year earlier and down 950.43 percentage points from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Longeveron's Return on Sales [ROS] was -1992.84% through Jun 30, 2026, down 1051.79 percentage points year-over-year; for FY2025, it was -1942.20%, down 1251.48 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -1875.09 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was -690.72% in FY2024 (+2275.29 pp), -2966.01% in FY2023 (-1489.49 pp), -1476.51% in FY2022 (-139.91 pp) and -1336.60% in FY2021 (-1269.48 pp).
- Quarterly Return on Sales [ROS] has moved between -8634.92% (Q4 2023) and -601.42% (Q3 2024) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of +425.62 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2024 (a gain of 7924.97 percentage points); the worst was Q3 2025 (a drop of 4734.34 percentage points).
- Per Business Quant data, LGVN's Return on Sales [ROS] in the three quarters before Q2 2026 was -1199.75% (Q1 2026), -1479.18% (Q4 2025) and -5335.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Longeveron | 7.81 Mn | -32.00 Mn | 182,000.00 | -2,150.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,150.17% |
| Mar 31, 2026 | -1,199.75% |
| Dec 31, 2025 | -1,479.18% |
| Sep 30, 2025 | -5,335.77% |
| Jun 30, 2025 | -1,707.91% |
| Mar 31, 2025 | -1,359.84% |
| Dec 31, 2024 | -709.95% |
| Sep 30, 2024 | -601.42% |
| Jun 30, 2024 | -747.86% |
| Mar 31, 2024 | -746.35% |
| Dec 31, 2023 | -8,634.92% |
| Sep 30, 2023 | -3,440.67% |
| Jun 30, 2023 | -2,632.26% |
| Mar 31, 2023 | -1,690.32% |
| Dec 31, 2022 | -4,331.40% |
| Sep 30, 2022 | -1,957.36% |
| Jun 30, 2022 | -905.79% |
| Mar 31, 2022 | -917.30% |
| Dec 31, 2021 | -1,929.19% |
| Sep 30, 2021 | -2,114.22% |
API Access
Longeveron Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();